1. Academic Validation
  2. In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2

In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2

  • Biochem Biophys Res Commun. 1999 Jan 27;254(3):693-8. doi: 10.1006/bbrc.1998.9995.
T Okuma 1 R Honda G Ichikawa N Tsumagari H Yasuda
Affiliations

Affiliation

  • 1 School of Life Science, Tokyo University of Pharmacy and Life Science, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0392, Japan.
Abstract

The SUMO-1 has been identified as a protein that is highly similar to ubiquitin and shown to conjugate to RanGAP1, PML, Sp200 and I kappa B alpha. The conjugation steps are thought to be similar to those of ubiquitination; and human Ubc9, which is homologous to the E2 Enzyme for the ubiquitin conjugation step, was identified and shown to be necessary for the conjugation of SUMO-1 to its target protein. Other essential Enzymes involved in this modification, however, remain to be clarified. Here we cloned human Sua1 (SUMO-1 activating Enzyme) and hUba2, which are human homologs of yeast Saccharomyces cerevisiae Aos1 and Uba2, respectively. The recombinant proteins, Sua1p and hUba2p, formed a complex. In this complex, hUba2 bound SUMO-1 and this complex had the activity of the SUMO-1 activating Enzyme. Furthermore, in an in vitro system, RanGAP1 was modified by SUMO-1 in the presence of Sua1p/Uba2p and hUbc9p, showing that the modification of SUMO-1 could be catalyzed by two Enzyme steps, although ubiquitination usually requires three Enzyme steps.

Figures